Brief: ContraFect Reports Q3 Loss Per Share $0.13
15/11/2021 12:42
Nov 15 (Reuters) - ContraFect Corp CFRX.O :
* CONTRAFECT REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
* Q3 LOSS PER SHARE $0.13
* EXPECTS TO CONDUCT PLANNED INTERIM FUTILITY ANALYSIS TO
ASSESS
SUPERIORITY OF EXEBACASE VERSUS SOCA ALONE IN FIRST HALF OF 2022
Source text for Eikon: ID:nGNX4k9XgL
Further company coverage: CFRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CONTRAFECT
See all newsBrief: Contrafect Corp - On Nov 7, Co Received Delisting Notification From Nasdaq Hearings Advisor Stating That Panel Determined To Delist Co's Common Stock
Brief: ContraFect Says Selling Securityholder May Offer And Selling Up To 7 Mln Shares In Aggregate Of Common Stock
Brief: Contrafect Announces FDA Clearance Of CF-370 IND Application To Proceed With Phase 1 Clinical Study
Brief: Contrafect Corp Says On Sept 21, Notified By Nasdaq, That Co Not In Compliance With The Minimum Bid Price Requirement
Brief: Contrafect Announces Submission Of Ind Application To The FDA For Its Development Candidate Cf-370